Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI)

Medication non-adherence is a major public health issue, and measuring non-adherence is a crucial step toward improving it. A paucity of retrievable data prevents researchers from effectively measuring, tracking and sharing outcomes on medication management. High quality data derived from prescribin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AMIA Summits on Translational Science proceedings 2015, Vol.2015, p.66-70
Hauptverfasser: Granger, Bradi B, Staton, Melodie, Peterson, Lindsay, Rusincovitch, Shelley A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Medication non-adherence is a major public health issue, and measuring non-adherence is a crucial step toward improving it. A paucity of retrievable data prevents researchers from effectively measuring, tracking and sharing outcomes on medication management. High quality data derived from prescribing patterns, including behavioral and technology-based interventions, is necessary to support meaningful use, improve publicly reported quality metrics, and develop strategies to improve medication management. Electronic health records make medication data more numerous and accessible, yet the reliability and utility of electronically available data elements that reflect adherence has not been well established. We sought to explore the types of medication-related data captured over time in a series of patient encounters (n=5500) in a population-based intervention in four U.S. counties in the SouthEastern Diabetes Initiative (SEDI). The purpose was to evaluate data generated through routine healthcare delivery that are repurposed (ie, "secondary use") for research/QI/population health.
ISSN:2153-4063
2153-4063